Global mRNA Vaccines & Therapeutics Market 2021

January 2022 | 20 pages | ID: GB3F6F6C67E4EN
StrategyHelix Inc

Abstracts

mRNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to treat a wide variety of diseases with high unmet medical needs. The global mRNA vaccines & therapeutics market is set to increase by US$ 13,119 million from 2021 to 2027, representing a compound annual growth rate (CAGR) of 4.7% during the forecast period. Rising consumer disposable income and living standards, rise in the geriatric population and growing prevalence of chronic diseases and rare disorders, growing cases of COVID-19 globally, favorable regulatory environment are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for mRNA vaccines & therapeutics. The global mRNA vaccines & therapeutics market is segmented on the basis of product, and region. On the basis of product, the global mRNA vaccines & therapeutics market has been segmented into mRNA vaccines, mRNA therapies. The mRNA vaccines segment is estimated to account for the largest share of the global mRNA vaccines & therapeutics market. In terms of geography, the global mRNA vaccines & therapeutics market has been segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The mRNA therapies market is further segmented into infectious diseases, oncology, rare disorders, and others. The infectious diseases segment held the largest share of the global mRNA vaccines & therapeutics market in 2020 and is anticipated to hold its share during the forecast period.

The global mRNA vaccines & therapeutics market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Arcturus Therapeutics Holdings Inc., BioNTech SE, CureVac N.V., ethris GmbH, Daiichi Sankyo Company Limited, GlaxoSmithKline plc, Moderna Inc., Translate Bio Inc., Johnson & Johnson, GreenLight Biosciences Inc., eTheRNA immunotherapies NV.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the mRNA vaccines & therapeutics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope
Product: mRNA vaccines, mRNA therapies
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global mRNA vaccines & therapeutics market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. MRNA VACCINES & THERAPEUTICS MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY PRODUCT

MRNA vaccines
MRNA therapies

PART 4. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 5. KEY COMPANIES

Arcturus Therapeutics Holdings Inc.
BioNTech SE
CureVac N.V.
ethris GmbH
Daiichi Sankyo Company, Limited
GlaxoSmithKline plc
Moderna, Inc.
Translate Bio, Inc.
Johnson & Johnson
GreenLight Biosciences, Inc.
eTheRNA immunotherapies NV
About StrategyHelix
Disclaimer